join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
Learn latest news of our company
follow developments of our company
News & Trends
27
2024-08
Salubris obtaining the exclusive right of base edi...
05
2024-08
The innovative anti-tumor drug JK06 was approved f...
01
2024-08
Enarodustat’s new indication approved for clinical...
31
2024-07
SAL0120 tablets for treatment of chronic kidney di...
05
2024-07
Innovative type 2 diabetes drug Fultagliptin benzo...
Learn more News & Trends